Skip to content

A randomised control trial of cognitive training and non-invasive brain stimulation in Parkinson's: The impact on cognition (thinking skills) and quality of life.

A randomised control trial of cognitive training and non-invasive brain stimulation in PD: The impact on cognition and quality of life.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12618000999235
Enrollment
41
Registered
2018-06-14
Start date
2019-01-07
Completion date
2027-06-30
Last updated
2026-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Research has demonstrated that people with Parkinson’s (PD) and mild cognitive impairment (PD- MCI) can improve their cognitive functioning using both cognitive training and transcranial direct current stimulation (tDCS) independently (e.g., Hindle et al., 2013). Pilot research by Lawrence and colleagues (2018), in this laboratory, suggests that the most effective improvement of PD-MCI occurs following cognitive training coupled with tDCS (compared to either intervention alone), where cognitive training was performed for 2 days per week and tDCS was delivered once per week (on a separate day to the training). The current study will extend these findings by adopting a randomised control trial approach to examine the impact of concurrent tDCS delivery and cognitive training on PD-MCI (that is, both interventions delivered at the same time). This study will examine the impact of standard cognitive training coupled with anodal tDCS over the left dorso-lateral prefrontal cortex (DLPFC) on cognition and quality of life (QOL), after controlling for self-reported sleep, hearing loss, motor symptoms, and mood in PD. A baseline assessment of motor and cognitive symptoms of PD, QOL, sleep, hearing loss, and mood will be completed 1 week prior to the intervention. Participants will be randomly assigned to 1 of 4 groups; (1) anodal (active) tDCS and cognitive training, (2) sham (control) tDCS and cognitive training, (3) anodal (active) tDCS and placebo (control) cognitive training, or (4) sham (control) tDCS and placebo (control) cognitive training. Participants in group 1 will receive 30 minutes of constant 1.5 mA stimulation over the left dorso-lateral prefrontal cortex (DLPFC) whilst simultaneously completing the cognitive training. Participants in group 2 will receive 30 minutes of sham (control) tDCS over left DLPFC whilst simultaneously completing the cognitive training. Participants in group 3 will receive 30 minutes of constant 1.5 mA stimulation over left DLPFC whilst simultaneously completing placebo cognitive training. Group 4 will receive 30 minutes of sham (control) tDCS over left DLPFC whilst simultaneously completing placebo cognitive training. Participants will complete two intervention sessions a week for 4 weeks, resulting in 8 sessions in total. Participants will complete post-intervention measures as at baseline, 1 and 12 weeks post-intervention. Participants will then complete a follow-up assessment at 12 weeks post-cessation. It is hypothesised that the participants receiving both active treatments concurrently will perform better on the cognitive measures and will report higher quality of life than participants receiving just one active treatment. In addition, participants receiving no active treatments will perform more poorly on the cognitive measures and report lower quality of life that participants receiving one or both active treatments.

Interventions

This study will use a dual-protocol intervention combining cognitive training and transcranial direct current stimulation (tDCS). These two interventions will be conducted simultaneously in each session. Upon study entry, participants will be assigned to one of the following 4 groups: 1. Anodal (active) tDCS and cognitive training (active) 2. Sham (control) tDCS and cognitive training (active) 3. Anodal (active) tDCS and placebo (control) cognitive training 4. Sham (control) tDCS and placebo (co

This study will use a dual-protocol intervention combining cognitive training and transcranial direct current stimulation (tDCS). These two interventions will be conducted simultaneously in each session. Upon study entry, participants will be assigned to one of the following 4 groups: 1. Anodal (active) tDCS and cognitive training (active) 2. Sham (control) tDCS and cognitive training (active) 3. Anodal (active) tDCS and placebo (control) cognitive training 4. Sham (control) tDCS and placebo (control) cognitive training. ARM 1 - Active Cognitive Training Participants in the active cognitive training groups (1 and 2) will complete cognitive training. Cognitive training will be conducted using MyBrainTrainerTM, a commercially available cognitive training package that runs via an online website. Participants will complete two 20-minute intervention sessions per week for 4-weeks (a total of 8 sessions). Jean, Bergeron, Thivierge, and Simard (2010) suggest that for people with MCI, 5 to 15 cognitive training sessions completed in less than 12 weeks are equally efficacious as longer and more costly interventions. In our experience, participants are likely to demonstrate fatigue after approximately 30 minutes of cognitive training which may impact their performance, hence the restricted duration of the intervention. Participants will complete a predetermined cognitive training program comprising five different exercises. These activities will include one short-term memory exercise, one executive function exercise, one information processing exercise, one working memory exercise, and one visual spatial exercise. Each exercise lasts approximately 3 – 4 minutes (depending on speed of response) and has a function for demonstration of the exercise before commencement. The program will halt after 20 minutes of training. In week one, participants will complete 2 identical training sessions comprising the 5 exercises at beginner’s level (sessions 1 and 2). In weeks 2 and 3, participants will complete 4 identical training sessions comprising the 5 exercises at intermediate level (sessions 3, 4, 5, and 6). In week 4, will complete 2 identical training sessions comprising the 5 exercises at advanced level (sessions 7 and 8) Online feedback (i.e. during the trials) will not be provided to the participant for any of the exercises, as this will help to reduce the risk of any distress associated with performance. Participants’ performance will be automatically monitored and recorded by the program, giving us an indication of the effectiveness of the training for each participant. For all exercises in all sessions, the researcher will provide verbal instructions and an example trial to demonstrate the task. Before commencing each exercise, the researcher will ask the participant if they understand the task and will give the participant an opportunity to ask questions about the instructions and, if required, demonstrate the task again. The program also provides written instructions on the screen just prior to commencement of the exercise. This intervention will be delivered by the project research assistant who has over 5 years experience with working in Parkinson's intervention trials. The research assistant is a psychology graduate. The intervention will be provided face-to-face and individually. ARM 2 - Active tDCS Participants in the active tDCS groups (the anodal (active) groups 1 and 3) will receive 20 minutes of constant current 1.5 mA (equivalent to 0.08 mA/cm2). Stimulation over the left dorsal lateral prefrontal cortex (DLPFC). This level is consistent with safety guidelines (Nitsche et al., 2008) and is well tolerated in those with PD-MCI (Lawrence et al., 2018). tDCS will be delivered by a constant current stimulator (Soterix®), which is administered using two 35 cm 2 sponge electrodes that have been soaked in saline solution. The anode electrode will be placed over F3 according to the 10-20 international system for EEG electrode placement, to stimulate the left DLPFC. The cathode (neutral) electrode will be position on the left side of the forehead. There will be a period of 30 seconds at the beginning and end of the tDCS for ramp up/down. tDCS will be delivered at the same time the participant is completing the cognitive training such that tDCS and cognitive training occur simultaneously for 20 minutes. This intervention will be administered by the project research assistant (as above) who is fully trained on the the set-up and administration of tDCS, and has previously completed a similar study as part of her Phd. The intervention will be delivered face-to-face and individually.

Sponsors

Professor Natalie Gasson
Lead SponsorIndividual

Study design

Allocation
Randomised controlled trial
Intervention model
Factorial
Primary purpose
Treatment
Masking
Blinded (masking used) (Subject)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1) Diagnosed with idiopathic PD by a neurologist or geriatrician in accordance with the United Kingdom Parkinson’s Disease Society Brain Bank Clinical (UKPDSBBC) criteria. 2) Self-reported problems with cognition which do not significantly impact on functional independence. 3) Presence of MCI in accordance with the MDS PD-MCI Level II diagnostic criteria, using an SD level of 1.5. 4) Stable response to antiparkinsonian medication for a minimum period of 2 months.

Exclusion criteria

1) Presence of PD-Dementia. 2) Recent history of brain surgery. 3) Deep Brain Stimulation (DBS) implant. 4) Active skin disease on the scalp. 5) History of migraine. 6) History of epilepsy. 7) Unstable medical condition (e.g., uncontrolled diabetes) 8) Metal implants in the head/brain. 9) Currently using a hearing aid.

Outcome results

None listed

Source: ANZCTR · Data processed: Sep 19, 2026